Skip Navigation LinksHome > January 2013 - Volume 21 - Issue 1 > Use of Ceftaroline in Complicated Methicillin-Resistant Stap...
Infectious Diseases in Clinical Practice:
doi: 10.1097/IPC.0b013e3182602205
Case Reports

Use of Ceftaroline in Complicated Methicillin-Resistant Staphylococcus aureus Bacteremia

Zainah, Hadeel MD; Vazquez, Jose A. MD

Collapse Box

Abstract

Abstract: Ceftaroline is a novel broad-spectrum cephalosporin approved in October 2010 by the Food and Drug Administration for the treatment of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections caused by different organisms, including methicillin-resistant Staphylococcus aureus. We report 2 cases where ceftaroline was used effectively to treat complicated methicillin-resistant S aureus bacteremia.

© 2013 Lippincott Williams & Wilkins, Inc.

Article Tools

Share

Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.